Skip to content

Author

Yi-Hsun Chan

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

507. Ketamine use disorder following intranasal esketamine for treatment-resistant depression: a case report and literature review

Abstract Background Esketamine, the S-enantiomer of ketamine, is an NMDA receptor antagonist approved for treatment-resistant depression (TRD). Although regulated clinical trials suggest a low risk of misuse, concerns remain that esketamine exposure may facilitate transition to ketamine dependence, particularly in East...

Yi-Hsun Chan, H.-M. Chang · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.